Pijush Chakraborty
Overview
Explore the profile of Pijush Chakraborty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taylor A, Xu Y, Wilkinson M, Chakraborty P, Brinkworth A, Willis L, et al.
J Am Chem Soc
. 2025 Feb;
PMID: 39985130
Amyloid formation is involved in widespread health conditions such as Alzheimer's disease, Parkinson's disease, and type-2 diabetes. Amyloid fibrils have a similar cross-β architecture, but fibrils formed by a single...
2.
Chakraborty P, Zweckstetter M
Nat Commun
. 2025 Jan;
16(1):669.
PMID: 39809798
The pathological deposition of tau and amyloid-beta into insoluble amyloid fibrils are pathological hallmarks of Alzheimer's disease. Molecular chaperones are important cellular factors contributing to the regulation of tau misfolding...
3.
Marvian A, Strauss T, Tang Q, Tuck B, Keeling S, Rudiger D, et al.
Mol Neurodegener
. 2024 Dec;
19(1):100.
PMID: 39736627
Background: The prion-like spreading of Tau pathology is the leading cause of disease progression in various tauopathies. A critical step in propagating pathologic Tau in the brain is the transport...
4.
Chakraborty P, de Opakua A, Purslow J, Fromm S, Chatterjee D, Zachrdla M, et al.
Proc Natl Acad Sci U S A
. 2024 Dec;
121(52):e2414176121.
PMID: 39693350
The pathological deposition of proteins is a hallmark of several devastating neurodegenerative diseases. These pathological deposits comprise aggregates of proteins that adopt distinct structures named strains. However, the molecular factors...
5.
Zhuang S, Chakraborty P, Zweckstetter M
Curr Opin Struct Biol
. 2023 Dec;
84:102739.
PMID: 38061261
Tau is an intrinsically disordered protein found abundantly in axons, where it binds to microtubules. Since tau is a central player in the dynamic microtubule network, it is highly regulated...
6.
Chakraborty P, Riviere G, Hebestreit A, de Opakua A, Vorberg I, Andreas L, et al.
Nat Commun
. 2023 Sep;
14(1):5919.
PMID: 37739953
Pathogenic aggregation of the protein tau is a hallmark of Alzheimer's disease and several other tauopathies. Tauopathies are characterized by the deposition of specific tau isoforms as disease-related tau filament...
7.
Chakraborty P, Zweckstetter M
Curr Opin Struct Biol
. 2023 Aug;
82:102678.
PMID: 37604044
Neurodegenerative diseases are associated with the pathological deposition of many different intrinsically disordered proteins or proteins with intrinsically disordered regions. Recent evidence suggests that these proteins can undergo liquid-liquid phase...
8.
Jiang L, Chakraborty P, Zhang L, Wong M, Hill S, Webber C, et al.
Sci Adv
. 2023 Feb;
9(5):eadd9789.
PMID: 36724228
Alzheimer's disease and related tauopathies are characterized by the pathogenic misfolding and aggregation of the microtubule-associated protein tau. Understanding how endogenous chaperones modulate tau misfolding could guide future therapies. Here,...
9.
Chakraborty P, Zweckstetter M
Essays Biochem
. 2022 Oct;
66(7):1013-1021.
PMID: 36251053
The aggregation and misfolding of the neuronal microtubule-associated protein tau is closely linked to the pathology of Alzheimer's disease and several other neurodegenerative diseases. Recent evidence suggest that tau undergoes...
10.
Chakraborty P, Riviere G, Liu S, de Opakua A, Dervisoglu R, Hebestreit A, et al.
Nat Commun
. 2021 Jul;
12(1):4231.
PMID: 34244499
Pathological aggregation of the protein tau into insoluble aggregates is a hallmark of neurodegenerative diseases. The emergence of disease-specific tau aggregate structures termed tau strains, however, remains elusive. Here we...